Interpreting treatment trials in schizophrenia patients: Lessons learned from EUFEST

Keyphrases

• Schizophrenia 100%
• Schizophrenic Patients 100%
• Last Observation Carried Forward 100%
• Haloperidol 100%
• Treatment Trials 100%
• Lessons Learned 100%
• First Episode 100%
• Negative Syndrome 100%
• Forward Analysis 100%
• Clinical Trials 50%
• Clinical Trial Design 50%
• Olanzapine 50%
• Ziprasidone 50%
• Second-generation Antipsychotics 50%
• Amisulpride 50%
• Quetiapine 50%
• Mixed Models 50%
• Mixed Model Analysis 50%
• Change Score 50%
• First-episode Patients 50%

Pharmacology, Toxicology and Pharmaceutical Science

• 4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol 100%
• Mixed Model 100%
• Positive Syndrome 100%
• Negative Syndrome 100%
• Clinical Trial 50%
• Olanzapine 50%
• Ziprasidone 50%
• Quetiapine 50%
• Amisulpride 50%
• Clinical Trial Design 50%

Neuroscience

• Positive Syndrome 100%
• Negative Syndrome 100%
• Haloperidol 100%
• Ziprasidone 50%
• Olanzapine 50%
• Quetiapine 50%
• Amisulpride 50%